MaxCyte MXCT Balance Sheet Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $14.56M-27.5% | $20.07M+54.7% | $12.97M-14.8% | $15.23M-34.9% | $23.39M-16.1% | ||
| $92.3M+11.2% | $82.98M-10.5% | $92.76M-16.7% | $111.34M-3.1% | $114.89M-9.3% | ||
| $4.25M+21.2% | $3.5M-57.8% | $8.31M+44.4% | $5.75M+4.1% | $5.53M+18.0% | ||
| $7.63M+1.1% | $7.55M-0.8% | $7.61M-4.1% | $7.93M-4.1% | $8.27M-7.2% | ||
| $4.21M-1.6% | $4.28M+42.5% | $3M+1.0% | $2.97M-19.2% | $3.68M+2.0% | ||
| $122.94M+3.9% | $118.37M-5.0% | $124.65M-13.0% | $143.22M-8.0% | $155.75M-9.3% | ||
| $16.64M-5.1% | $17.53M-5.8% | $18.62M-4.0% | $19.4M-2.6% | $19.92M+1.1% | ||
| $10.7M-2.0% | $10.92M-1.9% | $11.14M-1.8% | $11.34M-1.7% | $11.54M+7.2% | ||
| $783K+20.5% | $650K-2.5% | $667K+4.5% | $638K+28.1% | $498K— | ||
| $2.61M+5.6% | $2.47M-4.4% | $2.58M-7.7% | $2.8M+46.4% | $1.91M+24.7% | ||
| $40.81M-22.4% | $52.57M+0.6% | $52.27M+35.4% | $38.6M+6.0% | $36.42M+1.8% | ||
| $194.47M-4.0% | $202.51M-5.1% | $213.48M-2.9% | $219.75M-4.4% | $229.96M-4.0% | ||
| $1.2M-14.6% | $1.4M+8.9% | $1.29M+6.3% | $1.21M-46.9% | $2.28M+67.8% | ||
| $4.37M-44.0% | $7.81M-5.9% | $8.31M+29.8% | $6.4M+27.1% | $5.03M-39.4% | ||
| $3.27M-9.1% | $3.6M-30.8% | $5.2M+96.8% | $2.64M-36.3% | $4.15M-21.1% | ||
| $1.37M-5.6% | $1.46M+10.8% | $1.31M+0.5% | $1.31M+2.5% | $1.28M+47.7% | ||
| $10.21M-28.4% | $14.27M-11.4% | $16.1M+39.4% | $11.56M-9.3% | $12.73M-19.3% | ||
| $16.11M-2.3% | $16.49M-2.1% | $16.85M-2.0% | $17.2M-2.0% | $17.55M+2.2% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| $17.49M-2.5% | $17.94M-1.2% | $18.16M-1.9% | $18.51M-1.7% | $18.82M+4.4% | ||
| $262K-0.4% | $263K+15.9% | $227K-8.5% | $248K-8.1% | $270K-1.5% | ||
| $26.59M-14.3% | $31.02M-6.6% | $33.2M+14.4% | $29.03M-5.0% | $30.55M-8.0% | ||
| $1.07M+0.3% | $1.07M+0.2% | $1.07M0.0% | $1.07M+0.3% | $1.06M+0.6% | ||
| $433.05M+0.3% | $431.91M+0.2% | $431.1M+0.5% | $429.13M+0.9% | $425.46M+0.8% | ||
| -$266.23M-1.8% | -$261.48M-3.8% | -$251.89M-5.2% | -$239.47M-5.4% | -$227.11M-4.7% | ||
| $167.89M-2.1% | $171.49M-4.9% | $180.28M-5.5% | $190.72M-4.4% | $199.41M-3.3% | ||
| $194.47M-4.0% | $202.51M-5.1% | $213.48M-2.9% | $219.75M-4.4% | $229.96M-4.0% | ||
| $2.61M+5.6% | $2.47M-4.4% | $2.58M-7.7% | $2.8M+46.4% | $1.91M+24.7% | ||
| $10.7M-2.0% | $10.92M-1.9% | $11.14M-1.8% | $11.34M-1.7% | $11.54M+7.2% | ||
| $783K+20.5% | $650K-2.5% | $667K+4.5% | $638K+28.1% | $498K— | ||
| $40.81M-22.4% | $52.57M+0.6% | $52.27M+35.4% | $38.6M+6.0% | $36.42M+1.8% | ||
| $10.7M-2.0% | $10.92M-1.9% | $11.14M-1.8% | $11.34M-1.7% | $11.54M+7.2% | ||
| $2.61M+5.6% | $2.47M-4.4% | $2.58M-7.7% | $2.8M+46.4% | $1.91M+24.7% | ||
| $92.3M+11.2% | $82.98M-10.5% | $92.76M-16.7% | $111.34M-3.1% | $114.89M-9.3% | ||
| $10.7M-2.0% | $10.92M-1.9% | $11.14M-1.8% | $11.34M-1.7% | $11.54M+7.2% | ||
| $2.61M+5.6% | $2.47M-4.4% | $2.58M-7.7% | $2.8M+46.4% | $1.91M+24.7% | ||
| $3.27M-9.1% | $3.6M-30.8% | $5.2M+96.8% | $2.64M-36.3% | $4.15M-21.1% | ||
| $4.37M-44.0% | $7.81M-5.9% | $8.31M+29.8% | $6.4M+27.1% | $5.03M-39.4% | ||
| $17.49M-2.5% | $17.94M-1.2% | $18.16M-1.9% | $18.51M-1.7% | $18.82M+4.4% | ||
| $1.07M+0.3% | $1.07M+0.2% | $1.07M0.0% | $1.07M+0.3% | $1.06M+0.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are MaxCyte's total assets?
- MaxCyte (MXCT) holds $194.5M in total assets, down 15.4% year over year.
- How much debt does MaxCyte have?
- MaxCyte carries $17.5M in total debt against $167.9M of shareholders' equity, a debt-to-equity ratio of 0.10.
- How much cash does MaxCyte have?
- MaxCyte holds $14.6M in cash and equivalents.
- Can MaxCyte cover its short-term obligations?
- Its current ratio is 12.04 — current assets exceed current liabilities.
- Where does MaxCyte's balance sheet data come from?
- Every line is extracted from MaxCyte's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
